Topnav

Tag Archives | Pfizer

Champix trial results

Authors conclude no significant increase in serious neuropsychiatric adverse events with Champix relative to placebo or nicotine patch. Smokers treated with Champix had significantly higher quit rates than those treated with bupropion, nicotine patch or placebo. (more…)

Continue Reading · 0

Hidden faces of diabetes

Pfizer held its third Hidden Faces of Diabetes event, this time at the Sandton Hilton hotel, in Johannesburg chaired by Prof Larry Distiller. Medical Chronicle Editor, Claire Rush McMillan, covered the event. (more…)

Continue Reading · 0

Fighting for affordable meds

A number of patient groups and other leading health organisations have thrown their weight behind the ‘Fix the Patent Laws’ campaign initiated by Doctors Without Borders (MSF) and the Treatment Action Campaign in 2011. (more…)

Continue Reading · 0

Pfizer Mental Health Journalists of the Year Announced

In partnership with Pfizer SA, the SA Depression and Anxiety Group (SADAG) announced the names of this year’s recipients of the Pfizer Mental Health Journalism Awards. They are Mariette Snyman of Rooi Rose and Lynne Gidish, a freelance journalist, well known to consumer magazine readers. They received R25 000 each to assist in their research and […]

Continue Reading · 0